Trial Profile

Phase III, double-blind trial of lasofoxifene in postmenopausal with low or normal bone mineral density

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 30 Jan 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lasofoxifene (Primary)
Indications Postmenopausal osteoporosis
Focus Pharmacodynamics
Acronyms OPAL

Most Recent Events

18 Sep 2015 New trial record
16 Sep 2015 Results will be presented at the North American Menopause Society (NAMS) Annual Meeting 2015, according to a Sermonix Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com